Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription


1 Antimicrob Agents Chemother
2 Antiviral Res
1 Arch Virol
2 J Gen Virol
2 J Immunol
1 J Infect Dis
1 J Virol
1 Lancet Respir Med
1 PLoS Comput Biol
3 PLoS One
5 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Antimicrob Agents Chemother

  1. VIGIL A, Estelles A, Kauvar LM, Johnson SK, et al
    Native human monoclonal antibodies with potent cross-lineage neutralization of influenza B viruses.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.02269.
    PubMed     Text format     Abstract available

    Antiviral Res

    Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers.
    Antiviral Res. 2018 Mar 5. pii: S0166-3542(18)30065.
    PubMed     Text format     Abstract available

  3. GU H, Gao Y, Zhou S, Sun F, et al
    Bivalent vaccine platform based on ca influenza virus vaccine elicits protective immunity against human adenoviruses.
    Antiviral Res. 2018 Mar 1. pii: S0166-3542(17)30305.
    PubMed     Text format     Abstract available

    Arch Virol

  4. TAKIZAWA N, Kimura T, Watanabe T, Shibasaki M, et al
    Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis.
    Arch Virol. 2018 Mar 1. pii: 10.1007/s00705-018-3779.
    PubMed     Text format     Abstract available

    J Gen Virol

  5. STERTZ S, Paul Duprex W, Harris M
    A novel mutation in the neuraminidase gene of the 2009 pandemic H1N1 influenza A virus confers multidrug resistance.
    J Gen Virol. 2018;99:275-276.
    PubMed     Text format    

  6. KWON JJ, Choi WS, Jeong JH, Kim EH, et al
    An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    J Gen Virol. 2018;99:292-302.
    PubMed     Text format     Abstract available

    J Immunol

  7. TINOCO R, Carrette F, Henriquez ML, Fujita Y, et al
    Fucosyltransferase Induction during Influenza Virus Infection Is Required for the Generation of Functional Memory CD4(+) T Cells.
    J Immunol. 2018 Feb 28. pii: jimmunol.1701251. doi: 10.4049/jimmunol.1701251.
    PubMed     Text format     Abstract available

  8. WAGSTAFFE HR, Nielsen CM, Riley EM, Goodier MR, et al
    IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production.
    J Immunol. 2018 Feb 28. pii: jimmunol.1701614. doi: 10.4049/jimmunol.1701614.
    PubMed     Text format     Abstract available

    J Infect Dis

  9. ERBELDING EJ, Post D, Stemmy E, Roberts PC, et al
    A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
    J Infect Dis. 2018 Feb 28. pii: 4904047. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Virol

  10. WAN Y, Kang G, Sreenivasan C, Daharsh L, et al
    A DNA vaccine expressing consensus hemagglutinin-esterase fusion protein protected guinea pigs from infection by two lineages of influenza D virus.
    J Virol. 2018 Mar 7. pii: JVI.00110-18. doi: 10.1128/JVI.00110.
    PubMed     Text format     Abstract available

    Lancet Respir Med

  11. BRENDISH NJ, Malachira AK, Armstrong L, Houghton R, et al
    Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.
    Lancet Respir Med. 2017;5:401-411.
    PubMed     Text format     Abstract available

    PLoS Comput Biol

  12. LEE EC, Arab A, Goldlust SM, Viboud C, et al
    Deploying digital health data to optimize influenza surveillance at national and local scales.
    PLoS Comput Biol. 2018;14:e1006020.
    PubMed     Text format     Abstract available

    PLoS One

  13. ANDERSON KB, Simasathien S, Watanaveeradej V, Weg AL, et al
    Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.
    PLoS One. 2018;13:e0193050.
    PubMed     Text format     Abstract available

  14. BASILE L, Oviedo de la Fuente M, Torner N, Martinez A, et al
    Real-time predictive seasonal influenza model in Catalonia, Spain.
    PLoS One. 2018;13:e0193651.
    PubMed     Text format     Abstract available

  15. SINGH M, Toribio JA, Scott AB, Groves P, et al
    Assessing the probability of introduction and spread of avian influenza (AI) virus in commercial Australian poultry operations using an expert opinion elicitation.
    PLoS One. 2018;13:e0193730.
    PubMed     Text format     Abstract available


  16. CHIU C
    Novel immunological insights in accelerating RSV vaccine development.
    Vaccine. 2017;35:459-460.
    PubMed     Text format    

  17. AUGUST A, Glenn GM, Kpamegan E, Hickman SP, et al
    A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
    Vaccine. 2017 Jun 1. pii: S0264-410X(17)30681.
    PubMed     Text format     Abstract available

  18. CZAKO R, Vogel L, Sutton T, Matsuoka Y, et al
    H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30248.
    PubMed     Text format     Abstract available

  19. SURTEES TC, Teh BW, Slavin MA, Worth LJ, et al
    Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30297.
    PubMed     Text format     Abstract available

  20. SUNDARAM N, Duckett K, Yung CF, Thoon KC, et al
    "I wouldn't really believe statistics" - Challenges with influenza vaccine acceptance among healthcare workers in Singapore.
    Vaccine. 2018 Mar 5. pii: S0264-410X(18)30312.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.